Lawrence M Kauvar
Overview
Explore the profile of Lawrence M Kauvar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
662
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juarez M, ORourke S, Dzimianski J, Gagnon D, Penunuri G, Serrao V, et al.
Sci Rep
. 2025 Mar;
15(1):8666.
PMID: 40082629
Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease in infants and older adults. The attachment glycoprotein (RSV G) binds to the chemokine receptor CX3CR1...
2.
Cormier S, Kauvar L, Tripp R
Front Immunol
. 2025 Jan;
15:1529014.
PMID: 39759514
No abstract available.
3.
He L, Hertel L, James C, Morgan I, Klingelhutz A, Fu T, et al.
Antiviral Res
. 2024 Jul;
230:105971.
PMID: 39074588
Human cytomegalovirus (CMV) causes serious developmental disabilities in newborns infected in utero following oral acquisition by the mother. Thus, neutralizing antibodies in maternal saliva have potential to prevent maternal infection...
4.
Conway J, Delanois R, Mont M, Stavrakis A, McPherson E, Stolarski E, et al.
Antimicrob Agents Chemother
. 2024 Jul;
68(8):e0065524.
PMID: 39012102
Clinical Trials: This study is registered with ClinicalTrials.gov as NCT04763759.
5.
Burke Z, Hart C, Kelley B, Mamouei Z, Blumstein G, Hamad C, et al.
Antibiotics (Basel)
. 2023 Oct;
12(10).
PMID: 37887191
Bacterial biofilms on orthopedic implants are resistant to the host immune response and to traditional systemic antibiotics. Novel therapies are needed to improve patient outcomes. TRL1068 is a human monoclonal...
6.
Bergeron H, Murray J, Arora A, Nunez Castrejon A, DuBois R, Anderson L, et al.
Viruses
. 2023 May;
15(5).
PMID: 37243153
The respiratory syncytial virus (RSV) causes significant respiratory disease in young infants and the elderly. Immune prophylaxis in infants is currently limited to palivizumab, an anti-RSV fusion (F) protein monoclonal...
7.
Bergeron H, Kauvar L, Tripp R
Ther Adv Infect Dis
. 2023 Mar;
10:20499361231161157.
PMID: 36938145
Background: Respiratory syncytial virus (RSV) is a poor inducer of antiviral interferon (IFN) responses which result in incomplete immunity and RSV disease. Several RSV proteins alter antiviral responses, including the...
8.
Nunez Castrejon A, ORourke S, Kauvar L, DuBois R
J Virol
. 2022 Mar;
96(7):e0220121.
PMID: 35266806
Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease of children, the elderly, and immunocompromised individuals. Currently, there are no FDA-approved RSV vaccines. The RSV...
9.
Chatterjee N, Huang Y, Lyles K, Morgan J, Kauvar L, Greer S, et al.
J Infect Dis
. 2020 Aug;
223(8):1367-1375.
PMID: 32845315
Background: A vaccine against group A Streptococcus (GAS) has been actively pursued for decades. The surface receptor Shr is vital in GAS heme uptake and provides an effective target for...
10.
Qi Y, He L, Cui X, Hertel L, Freed D, Fu T, et al.
Virol J
. 2020 Apr;
17(1):50.
PMID: 32268919
Antibody neutralization of cytomegalovirus (CMV) entry into diverse cell types is a key consideration for development of vaccines and immunotherapeutics. CMV entry into fibroblasts differs significantly from entry into epithelial...